Aandelen in “Nierdialyse Centra”

Aandeel Datum Koers Evolutie
Geen effecten gevonden.

Nieuws over “Nierdialyse Centra”

22/04 · DaVita's Global Operations Powered by 100% Renewable Energy · Persbericht

22/04 · DaVita's Global Operations Powered by 100% Renewable Energy · Persbericht

18/04 · DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call · Persbericht

10/04 · DaVita Announces Dennis Pullin to its Board of Directors · Persbericht

22/03 · Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care · Persbericht

19/03 · Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device · Persbericht

13/03 · Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources · Persbericht

11/03 · The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On · Persbericht

8/03 · DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024 · Persbericht

5/03 · Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador · Persbericht

5/03 · DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador · Persbericht

1/03 · DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024 · Persbericht

20/02 · Fresenius Medical Care delivers on commitments in a year of fundamental transformation · Persbericht

13/02 · DaVita Inc. 4th Quarter 2023 Results · Persbericht

8/02 · Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies · Persbericht

5/02 · Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board · Persbericht

Mijn selecties